James L. Diebold
Publications by Year
Research Areas
Cancer therapeutics and mechanisms, Asymmetric Synthesis and Catalysis, Synthesis and biological activity, Catalytic C–H Functionalization Methods, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Synthesis Of 2-Aryl- and 2-Vinyl-1H-indoles via Palladium-Catalyzed Cross-Coupling of Aryl and Vinyl Halides with 1-Carboxy-2-(tributylstannyl)indole(1995)95 cited
- → Mixed-Lineage Kinase 1 and Mixed-Lineage Kinase 3 Subtype-Selective Dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: Optimization, Mixed-Lineage Kinase 1 Crystallography, and Oral in Vivo Activity in 1-Methyl-4-phenyltetrahydropyridine Models(2008)40 cited
- → Strategies to Mitigate the Bioactivation of 2-Anilino-7-Aryl-Pyrrolo[2,1-f][1,2,4]triazines: Identification of Orally Bioavailable, Efficacious ALK Inhibitors(2011)25 cited
- → 2,5-Benzodiazocines and intermediates(1967)21 cited
- → The Quasi-Favorskii Rearrangement. III.1 Rearrangement of (—)-1-Chloro-3,3-dimethylcyclohexyl 4-Dimethylaminophenyl Ketone(1965)17 cited
- → Fused Pyrrolo[2,3-c]carbazol-6-ones: Novel Immunostimulants That Enhance Human Interferon-γ Activity(1997)14 cited
- → Synthesis of the staurosporine aglycone (K-252c) lactam regioisomer(1997)14 cited
- → The Preparation of 1-Chlorocyclohexyl 4-Dimethylaminophenyl Ketone and 1-Chloro-3,3-dimethylcyclohexyl 4-Dimethylaminophenyl Ketone1(1965)5 cited
- → Interaction of 1,3-diaxial sulfur atoms(1968)3 cited
- The selective PARP inhibitor, CEP-8983 exhibits significant chemosensitization in combination with TMZ and SN38 against chemoresistant tumor cell lines and xenografts(2005)